Ensign Peak Advisors’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$642K Sell
104,678
-225,645
-68% -$1.88M ﹤0.01% 900
2025
Q4
$2.74M Sell
330,323
-4,750
-1% -$51.1K ﹤0.01% 645
2025
Q3
$4.89M Buy
335,073
+4,162
+1% +$49.8K 0.01% 592
2025
Q2
$3.72M Buy
330,911
+4,500
+1% +$34.9K 0.01% 704
2025
Q1
$1.86M Sell
326,411
-30
-0% -$306 ﹤0.01% 926
2024
Q4
$3.21M Hold
326,441
0.01% 777
2024
Q3
$2.66M Buy
326,441
+280,000
+603% +$2.81M ﹤0.01% 831
2024
Q2
$621K Sell
46,441
-35
-0.1% -$1.04K ﹤0.01% 1535
2024
Q1
$2.16M Sell
46,476
-2,028
-4% -$105K ﹤0.01% 896
2023
Q4
$3.28M Buy
48,504
+21,044
+77% +$1.29M 0.01% 730
2023
Q3
$1.99M Sell
27,460
-45
-0.2% -$3.6K ﹤0.01% 837
2023
Q2
$2.05M Sell
27,505
-58,581
-68% -$3.47M ﹤0.01% 868
2023
Q1
$4.58M Sell
86,086
-74
-0.1% -$4.69K 0.01% 598
2022
Q4
$5.82M Sell
86,160
-7,353
-8% -$676K 0.01% 528
2022
Q3
$11.7M Hold
93,513
0.03% 354
2022
Q2
$8.9M Buy
93,513
+7,353
+9% +$897K 0.02% 401
2022
Q1
$13.9M Sell
86,160
-7,353
-8% -$1.43M 0.03% 358
2021
Q4
$31.1M Buy
93,513
+91,500
+4,545% +$43.5M 0.06% 250
2021
Q3
$918K Buy
+2,013
New +$980K ﹤0.01% 1464

Other funds holding DNA